Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The Journal of urology Ročník 210; číslo 1; s. 46
Hlavní autori: Wei, John T, Barocas, Daniel, Carlsson, Sigrid, Coakley, Fergus, Eggener, Scott, Etzioni, Ruth, Fine, Samson W, Han, Misop, Kim, Sennett K, Kirkby, Erin, Konety, Badrinath R, Miner, Martin, Moses, Kelvin, Nissenberg, Merel G, Pinto, Peter A, Salami, Simpa S, Souter, Lesley, Thompson, Ian M, Lin, Daniel W
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.07.2023
Predmet:
Biopsy
Early Detection of Cancer - methods
Humans
Male
Mass Screening - methods
Prostate-Specific Antigen
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Systematic Reviews as Topic
early detection of prostate cancer
risk calculator
prostate cancer
DRE
screening interval
shared decision-making
biopsy
imaging
prostate cancer screening
PSA
ISSN:1527-3792, 1527-3792
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique. The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles. The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique. Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1527-3792
1527-3792
DOI:10.1097/JU.0000000000003491